-
Full Steam Ahead: uniQureās On Track With Hope for Accelerated Approval of Huntingtonās Disease Drug
Latest News
-
The 2025 HDBuzz Prize for Young Science Writers Is Open!
Announcing the 2025 HDBuzz Prize for Young Science Writers – sponsored by the Hereditary Disease Foundation!
-
May 2025: This Month in Huntingtonās Disease Research
From vision changes to genetic traffic jams and a clinical trial update, May was full of HD science excitement! Dive into our latest roundup to see how researchers are advancing Huntingtonās disease in exciting new ways.
-
Mind Your Mouth: Huntingtonās Disease and Oral Health
A recently published review discusses the challenges of dental care for people with HD, and the ways that informed dentists and medical teams can help to manage oral healthcare throughout the HD journey.
-
DNA Repair in Huntingtonās Disease: Not Up to Par?
Genetic mutations occur everyday in our cells, but the vast majority of them are repaired. New research finds DNA repair is not on PAR in HD cells, causing mutations to build up in people with HD.
-
Unlocking the Mindās Eye: How Huntingtonās Disease Changes How We See and Process the World
For many with Huntingtonās disease, recognising faces, navigating familiar places, or reading can be difficult. Scientists studied how and when HD affects how the brain processes what we seeācrucial research to improve support for people with HD.
-
Red Light, Green Light: How Huntingtonās Disease Influences Genetic Traffic Lights
Huntingtonās disease disrupts genetic "traffic lights," keeping genes green when they should be red. These genetic traffic jams may act to speed brain cell aging and faulty traffic cops fail to stop the chaos. What does this mean for HD?
-
Navigating the Genetic River: How Tiny Variants Could Shift the Course of Huntingtonās Disease
Hidden twists in the Huntingtonās disease gene could shift symptoms by over a decade! Scientists have uncovered rare āgenetic damsā that shape when HD begins – sometimes dramatically
-
Excitement and Anticipation as PTCās Huntingtonās Disease Drug Clears a Major Hurdle to Sprint Home
Votoplam, the daily pill from PTC Therapeutics, has met its primary endpoint in the PIVOT-HD clinical trial – it can lower huntingtin protein levels. This latest data update also provides insights into safety, biomarkers, and clinical measures.
-
Whatās Good for Your Heart is Good for Your Brain: New Study Links Cardiovascular Health to Brain Aging
Heart health has been linked to lower levels of NfL, a key biomarker of brain cell damage in Huntingtonās disease. This suggests heart-healthy habits – like exercise and diet – may have an effect on protecting the brain & keeping NfL in check.
-
Assembly Line Breakdown: Protein Production Problems in Huntingtonās Disease
Huntingtonās disease slows the cellās protein factory, causing production line jams & toxicity. A faulty blueprint & missing factory assistant worsen errors. Targeting production slowdowns, not just misfolded products, may help fix the assembly line.
-
April 2025: This Month in Huntingtonās Disease Research
HDBuzz has ramped up to match the accelerating pace of Huntingtonās disease research. April 2025 brought us insight on somatic expansion, replacing lost brain cells, and clinical trial updates. Read on for the highlight reel from this month!